Sara A. Hurvitz

Also affiliated with Fred Hutch Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.3Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Papers

Driven by 14 papers — median percentile 91. Top paper: “Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial”.

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Annals of Oncology(2020)10.1016/j.annonc.2020.05.012

N/A

3.1DataRank · unranked

106 citations

Sara A. Hurvitz, Jack A. Di Palma, Ron Bose, A. Jo Chien, Nicholas Iannotti +48 more

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

Cycling cancer persister cells arise from lineages with distinct programs

Nature(2021)10.1038/s41586-021-03796-6

N/A

0.933DataRank · unranked

502 citations

Michael Tsabar, Michael S. Cuoco, Liat Amir-Zilberstein, Jan-Christian Hütter, Bomiao Hu +18 more

Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5

Journal of Clinical Oncology(2024)10.1200/jco.23.02036

N/A

0.434DataRank · unranked

17 citations

Sara A. Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S. Rugo +11 more

Cycling cancer persister cells arise from lineages with distinct transcriptional and metabolic programs

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.05.136358

N/A

0.312DataRank · unranked

7 citations

Michael Tsabar, Michael S. Cuoco, Elma Zaganjor, Pratiksha I. Thakore, Marcin Tabaka +9 more

Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac052

N/A

0DataRank · unranked

40 citations

Patricia A. Ganz, Michael R. Irwin, Steve W. Cole, Judith Carroll, Kate R. Kuhlman +6 more

Acute health-related quality of life outcomes and systemic inflammatory markers following contemporary breast cancer surgery

npj Breast Cancer(2022)10.1038/s41523-022-00456-4

N/A

0DataRank · unranked

5 citations

Julienne E. Bower, Michael R. Irwin, Arash Asher, Sara A. Hurvitz, Steve W. Cole +3 more

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4191

N/A

0DataRank · unranked

94 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603.v1

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1552

N/A

0DataRank · unranked

12 citations

Shane A. Olwill, Erika Hamilton, Anthony W. Tolcher, Paula R. Pohlmann, Stephen V. Liu +16 more

Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination

Cancer(2025)10.1002/cncr.70038

N/A

0DataRank · unranked

5 citations

Arielle Radin, Patricia A. Ganz, Michael R. Irwin, Steve W. Cole, Laura Petersen +4 more

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2098

N/A

0DataRank · unranked

398 citations

Sara A. Hurvitz, Lida A. Mina, Hope S. Rugo, Ki Hoon Lee, Anthony Gonçalvès +15 more

Sara A. Hurvitz

Indexed papers

Top data-sharing exemplar

Papers